Israel

Royer Cooper Cohen Braunfeld LLC (RCCB) frequently advises Israeli companies doing business in the U.S. and U.S. companies doing business in Israel. The firm’s team consists of sophisticated attorneys who built a nimble firm that is highly qualified to work with innovative Israeli companies. In addition, our International Tax and Estate Planning Groups advise businesses and individuals on a wide variety of U.S./Israel dealings.

Members of our firm have strong connections to Israel and have been serving clients in Israel for more than 20 years. We help Israeli businesses and entrepreneurs with a “soft landing” in the United States as they launch or grow their businesses. We have an in-depth understanding of the needs of Israelis doing business in the U.S.

Our lawyers:

• Have advised close to 500 Israeli companies
• Lived and studied in Israel
• Served as in-house counsel to an international Israeli technology company
• Speak Hebrew
• Served in leadership capacities in organizations promoting business ties between Israel and the U.S.
• Visit Israel frequently for business
• Participate in and present at numerous Israeli venture conferences and events
• Led more than 10 Israel conferences in the U.S., helping more than 200 Israeli companies make meaningful U.S. connections

leadership and outreach

Neil Cooper and David Gitlin are past Philadelphia-Israel Chamber of Commerce presidents and serve on its Board of Directors. David Gitlin works from Tel Aviv approximately eight weeks per year. David has received an award from the Mayors of Philadelphia and Tel Aviv for promoting business ties between the two cities. 

Internationally ranked

Royer Cooper Cohen Braunfeld LLC (RCCB) achieved significant recognition within the legal landscape of Israel, as evidenced by its recent top rankings in the Legally Israel 100 League Tables. These rankings, which highlight international law firms significantly larger than RCCB, underscore RCCB's position as a leader in Israel-related deals and transactions. In the 7th annual league table rankings, RCCB secured impressive standings, ranking 10th for M&A volume and 12th for M&A value. This places RCCB among the world's foremost law firms proficient in servicing Israel-related transactions. Moreover, RCCB's Israel practice leader, David Gitlin, was singled out as a notable practitioner. His familiarity with Israel's culture and language and frequent visits to Israel highlight his instrumental role in facilitating RCCB's connections and operations within the region.

client Experience

• Private Equity & Venture Capital
• Securities and Private Offerings
• Mergers & Acquisitions
• Joint Ventures & Strategic Partnerships
• Trademarks & Copyrights
• Litigation
• Labor and Employment
• International Real Estate
• Technology Licensing
• International Tax
• Estate Planning

Experience

• RCCB represented Kafrit Industries (1993) Ltd., a leading global masterbatch producer for the plastics industry based in Israel, in the acquisition of a U.S. family-owned company providing high-quality and custom services in color concentrates. This $48 million deal was a strategic transaction for our client to expand its business in the U.S. RCCB provided tailored, strategic advice to the client and managed the deal process, including collaboration with Israeli counsel.
• Represented Cormed Ltd, a newly formed entity of three Israeli-based partners, who acquired substantially all of the assets of an Iowa company that manufacturers a closed system transfer device used in chemotherapy for a purchase price of $10 million plus earnouts with a total value equal to $20 million.
• Served as lead counsel to Lidorr Elements Ltd. in its strategic sale to Azelis Group NV, a global service provider with operations in 57 countries.
• Served as U.S. counsel on behalf of shareholders, including the Israeli private equity fund Tene Capital, in the sale of all the stock of TIBA Group, an Israel-based provider of turnkey parking site solutions, to the Italian company FAAC for $135 million.
• Acted as U.S. counsel for Cellect Biotechnology, Ltd., an Israeli company traded on NASDAQ, in connection with its merger with Quoin Pharmaceuticals, Inc. and with the sale of its subsidiary, Cellect Biotherapeutics, Ltd. to EnCellX, Inc.
• Represented a leading global digital engineering and software development public company with an NYSE market capitalization in excess of $9 billion and more than 30,000 employees in over 25 companies in its acquisition of an Israeli technology company and its U.S. subsidiary with big data, software development and cloud migration expertise. The company regularly relies on RCCB for counsel on some of its most significant and complex customer relationship and partner deals, and RCCB is integrated into the international legal structure to maximize business goals, as well as efficiency, timeliness, and cost-effectiveness. The deals are often complex, fast-paced, and high-volume. RCCB is frequently called upon to manage the deal process, including coordination of multiple internal and external stakeholders.
• Served as U.S. counsel to the shareholders of Habonim Industrial Valves & Actuators LTD, a world leader in pipe fittings, in the sale of Habonim to ITT Industries Luxemburg SARL for $140 million. Habonim is an Israeli company with global operations, including the U.S. Tene Investment Funds, a leading Israeli private equity firm, was Habonim's controlling shareholder.

View more.

• Represented North Carolina-based SJF Ventures in its investment in Israeli traffic optimization startup Waycare. SJF led the $7.3 million round, which included a number of other venture funds. Waycare has developed an artificial intelligence-based transportation management service to allow first responders to act before accidents develop into traffic jams. Read more at http://bit.ly/2OUuUKu.
• Represented Israel-based provider of application problem resolution software in its acquisition by a large U.S. software company, structuring and negotiating a complex stock purchase agreement that incorporated the use of a novel statutory "take along" provision.
• Represented the U.S. and Mexican agricultural products portfolio company of an Israeli private equity firm in connection with a $17 million receivables factoring transaction.
• Acted as U.S. counsel for a NASDAQ traded Israeli company in connection with its merger with a pharmaceutical company, as well as in connection with the sale of its subsidiary.
• Represented a consortium of two Israeli medical device companies and one private equity fund in the acquisition of substantially all of the assets of an Iowa company that manufactures a closed system transfer device used in chemotherapy.
• Represented a custom software design company with operations in the U.S. and Israel in connection with a strategic buyer’s acquisition of substantially all of the assets and liabilities of the company in exchange for equity.
• Represented a NYSE listed Philadelphia region-based provider of digital platform engineering and software development services in its acquisition of an Israeli big data and software development company and its US subsidiary.
• Represented a U.S. venture capital fund in a $4.5M Series A lead investment in an Israeli healthcare technology company.
• Represented a US-based corporation engaged in the development of alternative energy sources in a significant investment by a leading Israeli private equity fund.
• Represented an Israeli-based biotech company in a worldwide license and distribution agreement with a leading Italian pharma company.
• Represented Israel-based leading manufacturer of armored equipment in its acquisition of a Michigan-based defense contractor.